METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS

Approval Year

Substance Class	Structurally Diverse Created by `admin` on `Wed Apr 02 05:16:18 GMT 2025` Edited by `admin` on `Wed Apr 02 05:16:18 GMT 2025`
Source Materials Class	ORGANISM
Source Materials Type	BACTERIUM
Source Materials State	LIVE
Organism Family	Staphylococcaceae
Organism Genus	Staphylococcus
Organism Species	aureus
Author	ROSENBACH, 1884
Infraspecific Type	STRAIN
Infraspecific Name	METHICILLIN RESISTANCE
Part	whole
Record UNII	65P5WPF3BJ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MRSA

Preferred Name

English

METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS

Common Name

English

STAPHYLOCOCCUS AUREUS METHICILLIN RESISTANT

Common Name

English

Code System Code Type Description

FDA UNII

65P5WPF3BJ

Created by admin on Wed Apr 02 05:16:19 GMT 2025 , Edited by admin on Wed Apr 02 05:16:19 GMT 2025

PRIMARY

Related Record Type Details


					T6Z9V48IKG

GENTAMICIN

INHIBITOR->TARGET ORGANISM

Amount:


					0WX9996O2G

RAMOPLANIN

INHIBITOR->TARGET ORGANISM

Amount:


					PUG62FRZ2E

ORITAVANCIN

INHIBITOR->TARGET ORGANISM

Comments:

Efficacy and safety profiles of both dalbavancin and oritavancin were the same as vancomycin in the treatment of gram-positive bacterial infections in different clinical settings,

Amount:

21904A5386

LEFAMULIN

INHIBITOR->TARGET ORGANISM

Amount:


					3U02EL437C

CLINDAMYCIN

INHIBITOR->TARGET ORGANISM

Amount:


					92C2328G7P

OLANEXIDINE

INHIBITOR->TARGET ORGANISM

Amount:


					XT4808181K

LOTILIBCIN

INHIBITOR->TARGET ORGANISM

Amount:


					B669M62ELP

CONTEZOLID

INHIBITOR->TARGET ORGANISM

Amount:


					OZV2QPB39M

FLOPRISTIN

INHIBITOR->TARGET ORGANISM

Amount:


					C460ZSU1OW

EPEREZOLID

INHIBITOR->TARGET ORGANISM

Amount:


					JE42381TNV

SULFAMETHOXAZOLE

INHIBITOR->TARGET ORGANISM

Amount:


					P94L0PVO94

NEMONOXACIN

INHIBITOR->TARGET ORGANISM

Amount:


					DU69T8ZZPA

Rifamycin

INHIBITOR->TARGET ORGANISM

Amount:


					V72H9867WB

GARENOXACIN

INHIBITOR->TARGET ORGANISM

Amount:


					070SV15RJA

ACORAFLOXACIN

INHIBITOR->TARGET ORGANISM

Amount:


					XP2QP458K4

NARGENICIN

INHIBITOR->TARGET ORGANISM

Interaction Type:

PRECLINICAL

Amount:


					6315412YVF

DELAFLOXACIN

INHIBITOR->TARGET ORGANISM

Amount:


					26020H3Q1L

RAZUPENEM

INHIBITOR->TARGET ORGANISM

Amount:


					DVF0PR037D

Gepotidacin

INHIBITOR->TARGET ORGANISM

Amount:


					XK134822Z0

TELAVANCIN

INHIBITOR->TARGET ORGANISM

Amount:


					6Q205EH1VU

Vancomycin

INHIBITOR->TARGET ORGANISM

Amount:


					5T97333YZK

CEFTOBIPROLE

INHIBITOR->TARGET ORGANISM

Amount:


					CC9GT34DD3

RLP-068

INHIBITOR->TARGET ORGANISM

Comments:

With photodynamic therapy.

Amount:


					97HLQ82NGL

TEDIZOLID

INHIBITOR->TARGET ORGANISM

Amount:


					ISQ9I6J12J

LINEZOLID

INHIBITOR->TARGET ORGANISM

Amount:


					70JE2N95KR

TIGECYCLINE

INHIBITOR->TARGET ORGANISM

Amount:


					42445HUU0O

ICLAPRIM

INHIBITOR->TARGET ORGANISM

Amount:


					8WHH66L098

Levonadifloxacin

INHIBITOR->TARGET ORGANISM

Amount:


					N12000U13O

DOXYCYCLINE

INHIBITOR->TARGET ORGANISM

Amount:


					NWQ5N31VKK

DAPTOMYCIN

INHIBITOR->TARGET ORGANISM

Amount:


					R41ECT47G6

EXEPORFINIUM

INHIBITOR->TARGET ORGANISM

Amount:


					HO813QDF65

VOXVOGANAN

INHIBITOR->TARGET ORGANISM

Amount:


					090IP5RV8F

OMADACYCLINE

INHIBITOR->TARGET ORGANISM

Amount:


					53PC6LO35W

RADEZOLID

INHIBITOR->TARGET ORGANISM

Amount:


					I1679X069H

BRILACIDIN

INHIBITOR->TARGET ORGANISM

Amount:


					BB3RZX8UR5

Rx-01_423

INHIBITOR->TARGET ORGANISM

Qualification:

MIC

Amount:


					66974FR9Q1

CHLORAMPHENICOL

INHIBITOR->TARGET ORGANISM

Amount:


					55MOB566V7

LASCUFLOXACIN

INHIBITOR->TARGET ORGANISM

Amount:


					5X287491KH

EVERNIMICIN

INHIBITOR->TARGET ORGANISM

Amount:


					H36Z0FHR8K

CEFTAROLINE

INHIBITOR->TARGET ORGANISM

Amount:


					1654W9611T

TOMOPENEM

INHIBITOR->TARGET ORGANISM

Amount:


					808UI9MS5K

DALBAVANCIN

INHIBITOR->TARGET ORGANISM

Comments:

Efficacy and safety profiles of both dalbavancin and oritavancin were the same as vancomycin in the treatment of gram-positive bacterial infections in different clinical settings,

Amount:


					AN164J8Y0X

TRIMETHOPRIM

INHIBITOR->TARGET ORGANISM

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MIC	BIOLOGICAL				AGENT: FOSFOMYCIN